153 related articles for article (PubMed ID: 30393427)
1. Characteristics of surfactant proteins in tumorigenic and inflammatory lung lesions in rodents.
Yokohira M; Yamakawa K; Nakano-Narusawa Y; Hashimoto N; Kanie S; Yoshida S; Imaida K
J Toxicol Pathol; 2018 Oct; 31(4):231-240. PubMed ID: 30393427
[TBL] [Abstract][Full Text] [Related]
2. Suppressive effects of the expectorant drug ambroxol hydrochloride on quartz-induced lung inflammation in F344 rats.
Kanie S; Yokohira M; Yamakawa K; Nakano-Narusawa Y; Yoshida S; Hashimoto N; Imaida K
J Toxicol Pathol; 2017 Apr; 30(2):153-159. PubMed ID: 28458453
[TBL] [Abstract][Full Text] [Related]
3. Validating the use of napsin A as a marker for identifying tumorigenic potential of lung bronchiolo-alveolar hyperplasia in rodents.
Yokohira M; Nakano-Narusawa Y; Yamakawa K; Hashimoto N; Yoshida S; Kanie S; Imaida K
Exp Toxicol Pathol; 2017 Oct; 69(8):637-642. PubMed ID: 28602391
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical characteristics of surfactant proteins a, B, C and d in inflammatory and tumorigenic lung lesions of f344 rats.
Yokohira M; Yamakawa K; Nakano Y; Numano T; Furukawa F; Kishi S; Ninomiya F; Kanie S; Hitotsumachi H; Saoo K; Imaida K
J Toxicol Pathol; 2014 Oct; 27(3-4):175-82. PubMed ID: 25378802
[TBL] [Abstract][Full Text] [Related]
5. Effects of the expectorant drug ambroxol hydrochloride on chemically induced lung inflammatory and neoplastic lesions in rodents.
Yoshida S; Yokohira M; Yamakawa K; Nakano-Narusawa Y; Kanie S; Hashimoto N; Imaida K
J Toxicol Pathol; 2018 Oct; 31(4):255-265. PubMed ID: 30393429
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of the effect of ambroxol and dexamethasone on the expression of pulmonary surfactant proteins in the fetal rat lungs].
Fu XM; Yu JL; Liu GX; Deng B
Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):450-3. PubMed ID: 15265434
[TBL] [Abstract][Full Text] [Related]
7. Napsin A is possibly useful marker to predict the tumorigenic potential of lung bronchiolo-alveolar hyperplasia in F344 rats.
Yokohira M; Kishi S; Yamakawa K; Nakano Y; Ninomiya F; Kinouch S; Tanizawa J; Saoo K; Imaida K
Exp Toxicol Pathol; 2014 Mar; 66(2-3):117-23. PubMed ID: 24295539
[TBL] [Abstract][Full Text] [Related]
8. Cell-specific modulation of surfactant proteins by ambroxol treatment.
Seifart C; Clostermann U; Seifart U; Müller B; Vogelmeier C; von Wichert P; Fehrenbach H
Toxicol Appl Pharmacol; 2005 Feb; 203(1):27-35. PubMed ID: 15694461
[TBL] [Abstract][Full Text] [Related]
9. Involvement of napsin A in the C- and N-terminal processing of surfactant protein B in type-II pneumocytes of the human lung.
Brasch F; Ochs M; Kahne T; Guttentag S; Schauer-Vukasinovic V; Derrick M; Johnen G; Kapp N; Muller KM; Richter J; Giller T; Hawgood S; Buhling F
J Biol Chem; 2003 Dec; 278(49):49006-14. PubMed ID: 13129928
[TBL] [Abstract][Full Text] [Related]
10. The protective effect of different airway humidification liquids to lung after tracheotomy in traumatic brain injury: The role of pulmonary surfactant protein-A (SP-A).
Su X; Li Z; Wang M; Li Z; Wang Q; Lu W; Li X; Zhou Y; Xu H
Gene; 2016 Feb; 577(1):89-95. PubMed ID: 26611525
[TBL] [Abstract][Full Text] [Related]
11. Surfactant Protein A and Napsin A in the Immunohistochemical Characterization of Canine Pulmonary Carcinomas: Comparison With Thyroid Transcription Factor-1.
Beck J; Miller MA; Frank C; DuSold D; Ramos-Vara JA
Vet Pathol; 2017 Sep; 54(5):767-774. PubMed ID: 28578631
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of Napsin A in normal human fetal lungs at different gestational ages and in acquired and congenital pathological pulmonary conditions.
Giordano G; Campanini N; Varotti E
Virchows Arch; 2020 Oct; 477(4):557-563. PubMed ID: 32270298
[TBL] [Abstract][Full Text] [Related]
13. Lung remodeling in aging surfactant protein D deficient mice.
Schneider JP; Arkenau M; Knudsen L; Wedekind D; Ochs M
Ann Anat; 2017 May; 211():158-175. PubMed ID: 28185902
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary surfactant protein SP-B promotes exocytosis of lamellar bodies in alveolar type II cells.
Martínez-Calle M; Olmeda B; Dietl P; Frick M; Pérez-Gil J
FASEB J; 2018 Aug; 32(8):4600-4611. PubMed ID: 29543530
[TBL] [Abstract][Full Text] [Related]
15. Mice lacking CCAAt/enhancer-binding protein-alpha show hyperproliferation of alveolar type II cells and increased surfactant protein mRNAs.
Sugahara K; Iyama KI; Kimura T; Sano K; Darlington GJ; Akiba T; Takiguchi M
Cell Tissue Res; 2001 Oct; 306(1):57-63. PubMed ID: 11683182
[TBL] [Abstract][Full Text] [Related]
16. Expression of surfactant protein mRNA in normal and neoplastic lung of B6C3F1 mice as demonstrated by in situ hybridization.
Pilling AM; Mifsud NA; Jones SA; Endersby-Wood HJ; Turton JA
Vet Pathol; 1999 Jan; 36(1):57-63. PubMed ID: 9921757
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced mitogenic factor modulates surfactant protein B and C expression in mouse lung.
Tong Q; Zheng L; Dodd-o J; Langer J; Wang D; Li D
Am J Respir Cell Mol Biol; 2006 Jan; 34(1):28-38. PubMed ID: 16166744
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of surfactant protein SP-A, SP-B, and SP-C mRNA in rat lungs with lipopolysaccharide-induced injury.
Sugahara K; Iyama K; Sano K; Kuroki Y; Akino T; Matsumoto M
Lab Invest; 1996 Jan; 74(1):209-20. PubMed ID: 8569184
[TBL] [Abstract][Full Text] [Related]
19. Surfactant proteins in pulmonary alveolar proteinosis in adults.
Brasch F; Birzele J; Ochs M; Guttentag SH; Schoch OD; Boehler A; Beers MF; Müller KM; Hawgood S; Johnen G
Eur Respir J; 2004 Sep; 24(3):426-35. PubMed ID: 15358702
[TBL] [Abstract][Full Text] [Related]
20. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Bishop JA; Sharma R; Illei PB
Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
